Preclinical Imaging Market Size, Demand to 2035
Introduction:
The Global Preclinical Imaging Market focuses on imaging technologies used to observe living organisms and support research into drug development, disease mechanisms, and new medical treatments. Preclinical imaging enables researchers to obtain detailed information through advanced and non-invasive imaging technologies.
Increasing chronic diseases, growing demand for personalised medicine, advances in imaging technologies, rising research and development activities, and increasing funding for preclinical research are supporting market growth. The growing use of artificial intelligence for medical image processing is also contributing to technological advancements in the market.
Get Free Sample of This Premium Report: https://www.decisionsadvisors.com/request-sample/DAR2375
Global Preclinical Imaging Market Insights
- Based on Decisions Advisors findings, the Global Preclinical Imaging Market was valued at approximately USD 3.59 Billion in 2024 and is projected to reach USD 5.71 Billion by 2035.
- From 2025 to 2035, the global market is expected to grow at a CAGR of 4.31%.
- The Modality segment accounted for the largest market share in 2024 and is expected to grow at a substantial CAGR during the forecast period.
- The Research Institutes segment accounted for the highest market share in 2024 and is anticipated to grow at a rapid pace during the forecast period.
Other Key Findings
- Europe is expected to grow at the fastest pace during the forecast period, supported by increasing R&D expenditure, government grants, pharmaceutical and biotechnology research, and demand for translational research.
- Asia Pacific is anticipated to hold the largest share of the Global Preclinical Imaging Market, supported by lower research costs, fewer research limitations, and increasing government funding for research and development.
- The market is segmented by product into Modality, Reagent, and Service.
- By end user, the market is segmented into Biotech Companies, Pharmaceutical Companies, and Research Institutes.
Report Summary
|
Report Scope |
Details |
|
Base Year for Study |
2024 |
|
Study Period |
2021–2035 |
|
Historical Period |
2021–2024 |
|
Forecast Period |
2025–2035 |
|
Market Size In 2024 |
USD 3.59 Billion |
|
Market Size In 2035 |
USD 5.71 Billion |
|
Largest segment |
Modality |
|
Units |
Revenue in USD Billion |
|
CAGR |
4.31% (2025–2035) |
|
Segmentation Covered |
|
|
By Product |
|
|
By End User |
|
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, Environment & Regulatory Landscape and Trends |
|
Companies |
Aspect Imaging, Bruker Corporation, Cubresa Inc., FUJIFILM VisualSonics, Mediso Ltd., MR Solutions, Revvity (PerkinElmer, Inc), Rigaku (MILabs B.V.), Siemens Healthineers, TriFoil Imaging, and Others. |
Want detailed insights, forecasts, and competitive analysis?
Check out the full report now: https://www.decisionsadvisors.com/reports/preclinical-imaging-market
Connect with us
- USA - +1 303 800 4326
- APAC - +1 303 800 4326
- [email protected]